Business Standard

Zydus and Pharm Aid tie up for vaccine technology for Russia

The exclusive agreement was signed at the BIOTECHMED conference in Gelendzhik, Russia

Zydus acquires derma brand Melgain from Issar Pharma
Premium

Bs Reporter Ahmedabad
Cadila Healthcare Limited (Zydus Cadila), has entered into an exclusive agreement for the technical know-how for varicella vaccine production in the Russian Federation with Pharm Aid Ltd, headquartered in Russia. Pharm Aid Ltd, has been set up by Nacimbio together with Ishvan Pharmaceuticals Ltd, for the localisation of innovative vaccine production in Russia.

Pharm Aid Ltd was set up in May 2017 as a joint venture of Russian National Immunobiological Company (Nacimbio) that represents the pharmaceutical group of Rostec State Corporation and Ishvan Pharmaceutical Ltd from UAE in 51-49 ratio. The company aims to partner with leading global pharma companies

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in